10 Top Women in Biotech 2012

Source:

"Too few female professionals rise to senior executive roles in the biopharma industry, making the accomplishments of these women all the more exceptional."

Dr. Lynn Seely of Medivation ($MDVN) is spearheading the team that took Xtandi, a likely blockbuster for prostate cancer patients, all the way through the clinic to a first approval. At 23andMe, Anne Wojcicki aims to "connect" patients with genetic information that can help them take control of their own health. And Dr. Michelle Dipp of OvaScience wants to revolutionize the treatment of female infertility.

FierceBiotech's "10 Top Women in Biotech" honorees this year are top innovators in life sciences. Too few female professionals rise to senior executive roles in the biopharma industry, making the accomplishments of these women all the more exceptional. . .View Full Article

Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe